GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Lifted by Xponance Inc.

Xponance Inc. increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,810 shares of the company’s stock after buying an additional 5,346 shares during the quarter. Xponance Inc.’s holdings in GE HealthCare Technologies were worth $5,380,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Intech Investment Management LLC boosted its position in GE HealthCare Technologies by 1,429.4% during the fourth quarter. Intech Investment Management LLC now owns 312,080 shares of the company’s stock valued at $24,398,000 after purchasing an additional 291,675 shares during the last quarter. Horizon Investments LLC boosted its position in GE HealthCare Technologies by 3.8% during the fourth quarter. Horizon Investments LLC now owns 5,983 shares of the company’s stock valued at $468,000 after purchasing an additional 221 shares during the last quarter. Advisors Asset Management Inc. boosted its position in GE HealthCare Technologies by 7.1% during the fourth quarter. Advisors Asset Management Inc. now owns 104,343 shares of the company’s stock valued at $8,158,000 after purchasing an additional 6,913 shares during the last quarter. Thrivent Financial for Lutherans boosted its position in GE HealthCare Technologies by 48.6% during the fourth quarter. Thrivent Financial for Lutherans now owns 37,756 shares of the company’s stock valued at $2,978,000 after purchasing an additional 12,348 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. boosted its position in GE HealthCare Technologies by 69.5% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 3,803 shares of the company’s stock valued at $297,000 after purchasing an additional 1,559 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.3 %

Shares of GEHC opened at $82.40 on Thursday. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $37.68 billion, a price-to-earnings ratio of 19.03, a P/E/G ratio of 3.19 and a beta of 1.13. The stock’s 50-day moving average price is $87.17 and its 200 day moving average price is $86.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on GEHC. Citigroup lifted their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.